Capital Markets Trading (UK)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.96M Buy
236,216
+189,245
+403% +$3.17M 0.07% 4
2025
Q1
$722K Sell
46,971
-457,001
-91% -$7.02M 0.01% 39
2024
Q4
$11.1M Buy
503,972
+137,298
+37% +$3.03M 0.17% 2
2024
Q3
$6.61M Sell
366,674
-80,735
-18% -$1.45M 0.09% 2
2024
Q2
$7.27M Buy
447,409
+328,159
+275% +$5.33M 0.11% 2
2024
Q1
$1.68M Buy
119,250
+18,402
+18% +$260K 0.02% 27
2023
Q4
$1.05M Sell
100,848
-33,767
-25% -$353K 0.01% 34
2023
Q3
$1.37M Buy
+134,615
New +$1.37M 0.02% 30
2023
Q2
Hold
0
116
2023
Q1
Sell
-258,241
Closed -$2.36M 112
2022
Q4
$2.36M Sell
258,241
-506,623
-66% -$4.62M 0.05% 3
2022
Q3
$6.17M Buy
764,864
+683,013
+834% +$5.51M 0.13% 3
2022
Q2
$616K Sell
81,851
-63,395
-44% -$477K 0.01% 27
2022
Q1
$1.36M Sell
145,246
-1,003,223
-87% -$9.42M 0.02% 19
2021
Q4
$9.2M Buy
1,148,469
+412,137
+56% +$3.3M 0.12% 2
2021
Q3
$7.34M Sell
736,332
-32,797
-4% -$327K 0.1% 3
2021
Q2
$7.61M Buy
769,129
+509,589
+196% +$5.04M 0.12% 3
2021
Q1
$3M Buy
259,540
+69,836
+37% +$806K 0.05% 8
2020
Q4
$1.83M Sell
189,704
-115,282
-38% -$1.11M 0.02% 9
2020
Q3
$2.83M Buy
304,986
+233,051
+324% +$2.16M 0.04% 12
2020
Q2
$887K Buy
+71,935
New +$887K 0.02% 27
2020
Q1
Hold
0
107
2019
Q4
Sell
-95,563
Closed -$657K 74
2019
Q3
$657K Sell
95,563
-46,780
-33% -$322K 0.03% 26
2019
Q2
$1.31M Buy
142,343
+117,656
+477% +$1.09M 0.06% 18
2019
Q1
$387K Buy
24,687
+5,651
+30% +$88.6K 0.02% 25
2018
Q4
$294K Sell
19,036
-6,336
-25% -$97.9K 0.02% 29
2018
Q3
$547K Buy
25,372
+7,320
+41% +$158K 0.03% 30
2018
Q2
$439K Buy
+18,052
New +$439K 0.02% 31
2018
Q1
Sell
-10,949
Closed -$207K 65
2017
Q4
$207K Buy
+10,949
New +$207K 0.01% 30